MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

MDS Patient & Family Podcast

This new initiative of the MDS Foundation is devoted to MDS patients, family members and caregivers. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc. They will also answer frequently asked questions.

The explosion of information on MDS forces us to seek novel, alternative ways to distribute it.  Podcasts gives us an easy and popular way to communicate this information in a short time.


  • Listen on Spotify
  • Season 3
    • Welcome to Season 3 of the MDS Patient & Family Report.

      Thank you to Geron, Jazz Pharmaceuticals and Taiho Oncology for supporting this initiative.

      Season 3 : Episode 2:

      Overview of MDS treatments

      Dr. Nikolaos Papadantonakis

      Dr. Papadantonakis from Winship Cancer Institute of Emory University, Atlanta, US, and Dr. Mittelman, chairman of the MDS Foundation scientific board, discuss the range of treatment options for patients with MDS.

    • Season 3 : Episode 1:

      New drugs for anemia of lower-risk MDS

      Dr. Nikolaos Papadantonakis

      MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.

Thank you to BMS, Gilead Sciences, Inc., Jazz Pharmaceuticals Inc. and Taiho Oncology, Inc. for supporting this initiative.

Review answers to commonly asked questions or get answers to your questions from an MDS expert